Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed)
The summary for the Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed): The purpose of this funding opportunity is to encourage small businesses to develop technologies and approaches (i.e., novel ways to use new or existing technologies) that will enable researchers to better understand and manipulate the dynamic structure and/or function of brain localized G-protein coupled receptors (GPCRs) and/or potentially identify novel selective and specific agonists, antagonists, or allosteric modulators for these receptor subtypes, with a focus on mental health function or dysfunction. Technologies and approaches aimed at either well characterized receptor subtypes or understudied/orphan receptors would be of potential interest to NIMH.
Federal Grant Title: | Novel Tools for Investigating Brain-derived GPCRs in Mental Health Research (R43/R44 Clinical Trial Not Allowed) |
Federal Agency Name: | National Institutes of Health (HHS-NIH11) |
Grant Categories: | Health |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-18-708 |
Type of Funding: | Grant |
CFDA Numbers: | 93.242 |
CFDA Descriptions: | Information not provided |
Current Application Deadline: | September 5th, 2021 |
Original Application Deadline: | September 5th, 2021 |
Posted Date: | March 15th, 2018 |
Creation Date: | March 15th, 2018 |
Archive Date: | October 11th, 2021 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
Last Updated: | March 15th, 2018 |
- Applicants Eligible for this Grant
- Small businesses
- Additional Information on Eligibility
- Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed. see the funding opportunity for eligibility details
- Link to Full Grant Announcement
- http://grants.nih.gov/grants/guide/pa-files/PA-18-708.html
- Grant Announcement Contact
- NIH OER Webmaster
[email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster - Similar Government Grants
- • Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 ...
- • Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
- • Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R3...
- • Discovery of in vivo Chemical Probes for the Nervous System (R01 Clinical Trial Not Allowe...
- • Streamlining mental health interventions for youth living with HIV in Low- and Middle-Inco...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities: (STTR [R41/R4...
- • Development of Biomarkers for Mental Health Research and Clinical Utilities (SBIR [R43/R44...
- • Pharmacologic Agents and Drugs for Mental Disorders (SBIR [R43/R44])
- More Grants from the National Institutes of Health
- • Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- • Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- • Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clin...
- • Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Tr...
- • Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data...